Literature DB >> 15604012

CD107a as a functional marker for the identification of natural killer cell activity.

Galit Alter1, Jessica M Malenfant, Marcus Altfeld.   

Abstract

Natural killer (NK) cells are a subset of lymphocytes that play a central role in the innate immune response to tumors and infections. An important limitation in the field of NK research is attributable to the deficit of assays available for the detection of the functional activity of NK cells. Recently, lysosomal-associated membrane protein-1 (LAMP-1 or CD107a) has been described as a marker of CD8+ T-cell degranulation following stimulation. Here we describe CD107a as a marker of NK cell functional activity using multi-parameter flow cytometry. CD107a is significantly upregulated on the surface of NK cells following stimulation with MHC devoid targets. Additionally, CD107a expression correlates with both cytokine secretion and NK cell-mediated lysis of target cells. However, as well as being coordinately expressed on nearly all cytokine secreting cells, CD107a was also expressed on a large subset of NK cells that did not secrete cytokine following stimulation. These data suggest that employing CD107a as a marker of NK cell functional activity may allow for the identification of a large fraction of activated NK cells that may degranulate in the absence of cytokine secretion. Cumulatively, the data presented here demonstrate that CD107a is a sensitive marker of NK cell activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604012     DOI: 10.1016/j.jim.2004.08.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  563 in total

1.  Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.

Authors:  J Brian Kimble; Delphine C Malherbe; Michelle Meyer; Bronwyn M Gunn; Marcus M Karim; Philipp A Ilinykh; Mathieu Iampietro; Khaled S Mohamed; Surendra Negi; Pavlo Gilchuk; Kai Huang; Yuri I Wolf; Werner Braun; James E Crowe; Galit Alter; Alexander Bukreyev
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  IL-7Rαlow memory CD8+ T cells are significantly elevated in patients with systemic lupus erythematosus.

Authors:  Jung-Sik Kim; Bon-A Cho; Ji Hyun Sim; Kamini Shah; Connie M Woo; Eun Bong Lee; Dong-Sup Lee; Jae Seung Kang; Wang Jae Lee; Chung-Gyu Park; Joe Craft; Insoo Kang; Hang-Rae Kim
Journal:  Rheumatology (Oxford)       Date:  2012-06-01       Impact factor: 7.580

3.  Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17.

Authors:  Jing Ren; Yunzhong Nie; Mingming Lv; Sunan Shen; Ruijing Tang; Yujun Xu; Yayi Hou; Shuli Zhao; Tingting Wang
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

4.  Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Authors:  Joo Chun Yoon; Jong-Baeck Lim; Jeon Han Park; Jae Myun Lee
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 5.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

6.  Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection.

Authors:  Hailong Guo; David J Topham
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

7.  TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets.

Authors:  Stephanie C Heidemann; Valerie Chavez; Carol J Landers; Torsten Kucharzik; John L Prehn; Stephan R Targan
Journal:  J Clin Immunol       Date:  2010-03-27       Impact factor: 8.317

8.  The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.

Authors:  Hong-Sheng Dai; Nathaniel Griffin; Chelsea Bolyard; Hsiaoyin Charlene Mao; Jianying Zhang; Timothy P Cripe; Tadahiro Suenaga; Hisashi Arase; Ichiro Nakano; E A Chiocca; Balveen Kaur; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

9.  Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.

Authors:  Holbrook E Kohrt; Ariane Thielens; Aurelien Marabelle; Idit Sagiv-Barfi; Caroline Sola; Fabien Chanuc; Nicolas Fuseri; Cécile Bonnafous; Debra Czerwinski; Amanda Rajapaksa; Erin Waller; Sophie Ugolini; Eric Vivier; François Romagné; Ronald Levy; Mathieu Bléry; Pascale André
Journal:  Blood       Date:  2013-12-10       Impact factor: 22.113

10.  Improving STING Agonist Delivery for Cancer Immunotherapy Using Biodegradable Mesoporous Silica Nanoparticles.

Authors:  Kyung Soo Park; Cheng Xu; Xiaoqi Sun; Cameron Louttit; James J Moon
Journal:  Adv Ther (Weinh)       Date:  2020-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.